Skip to main content
. Author manuscript; available in PMC: 2020 Jan 10.
Published in final edited form as: Int J Pharm. 2018 Nov 5;554:212–223. doi: 10.1016/j.ijpharm.2018.11.011

Figure 3.

Figure 3.

Characteristics of nanoparticles. (A) Drug release profiles of (i) BSA and (ii) coumarin-6 from PLGA, UPE and BPLP-PLGA NPs show UPE nanoparticles displaying slower and more sustained drug release. (B) Degradation profiles of these nanoparticles show weight loss of the NPs with time indicating biodegradability.